Amr I. Al Abbas - Concepedia

Author

Amr I. Al Abbas

The University of Texas Southwestern Medical Center ORCID

Also Known As

A. Abbas, A. I. Al Abbas, A.I. Al Abbas, A.I. Al-Abbas, Al-Abbas, Amr, Alia Abbas, Amr Al Abbas, Amr Al-Abbas, Amr Al-abbas, Amr I Al Abbas

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center University of Pittsburgh Medical Center NorthShore University HealthSystem University of Pittsburgh West Virginia University

About

Amr I. Al Abbas is an author at The University of Texas Southwestern Medical Center specializing in medicine, surgery, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	842
2	Education	2	2	71
3	Engineering	2	2	94
4	Health Sciences	1	1	71
5	Diabetes	1	1	39

Amr I. Al Abbas

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
500 Minimally Invasive Robotic Pancreatoduodenectomies Amer H. Zureikat, Joal D. Beane, Mazen S. Zenati, Annals of Surgery	2019	191
Association of Mentorship and a Formal Robotic Proficiency Skills Curriculum With Subsequent Generations’ Learning Curve and Safety for Robotic Pancreaticoduodenectomy MaryJoe K. Rice, Jacob C. Hodges, Johanna Bellon, JAMA Surgery	2020	92
Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship Lawrence M. Knab, Mazen S. Zenati, Anton Khodakov, Annals of Surgical Oncology Medical RobotSurgical OncologyOncologyRoboticsEngineering	2018	81
Robotic Pancreaticoduodenectomy Is Associated with Decreased Clinically Relevant Pancreatic Fistulas: a Propensity-Matched Analysis Jianpeng Cai, Rajesh Ramanathan, Mazen S. Zenati, Journal of Gastrointestinal Surgery UrologyPancreatic CancerPancreatic Fluid CollectionRobotic TechnologyPropensity-matched Analysis	2019	80
Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer Pranav Murthy, Mazen S. Zenati, Amr I. Al Abbas, Annals of Surgical Oncology Surgical OncologyPancreatic CancerCancer ImmunosurveillanceMedicinePrognostic Value	2019	76
CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time Caroline J. Rieser, Mazen S. Zenati, Ahmad Hamad, Annals of Surgical Oncology Surgical OncologyPancreatic CancerMedicineSurgical PathologyChanging Prognosis	2018	71
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma Amr I. Al Abbas, Mazen S. Zenati, Caroline J. Reiser, Annals of Surgical Oncology Surgical OncologyPancreatic CancerGastrointestinal OncologySerum Ca19-9 ResponseMedicine	2020	67
CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer Hao Liu, Mazen S. Zenati, Caroline J. Rieser, Annals of Surgical Oncology Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicinePathology	2020	56
Prevalence of gastroesophageal reflux and risk factors for erosive esophagitis in obese patients considered for bariatric surgery Ala I. Sharara, Luma Basma O. Rustom, Halim Bou Daher, Digestive and Liver Disease ObesityBariatric SurgeryEsophagusSleeve GastrectomyGastroenterology	2019	55
Long-Term Surgical Complications After Pancreatoduodenectomy: Incidence, Outcomes, and Risk Factors James A. Brown, Mazen S. Zenati, Richard L. Simmons, Journal of Gastrointestinal Surgery Pancreatic CancerGastroenterologyPancreatic SurgerySurgeryMedicine	2020	54

Page 1